MINETTO, PAOLA
 Distribuzione geografica
Continente #
EU - Europa 3.661
AS - Asia 461
NA - Nord America 328
SA - Sud America 56
AF - Africa 6
OC - Oceania 3
Totale 4.515
Nazione #
IT - Italia 3.561
US - Stati Uniti d'America 295
SG - Singapore 183
CN - Cina 135
VN - Vietnam 81
BR - Brasile 37
FR - Francia 33
FI - Finlandia 22
BD - Bangladesh 17
CA - Canada 16
HK - Hong Kong 10
AR - Argentina 9
DE - Germania 8
IN - India 7
MX - Messico 7
CH - Svizzera 5
GB - Regno Unito 5
IQ - Iraq 5
JP - Giappone 5
TR - Turchia 5
AU - Australia 3
CO - Colombia 3
GR - Grecia 3
ID - Indonesia 3
NI - Nicaragua 3
NL - Olanda 3
RU - Federazione Russa 3
BE - Belgio 2
DZ - Algeria 2
EC - Ecuador 2
ES - Italia 2
PH - Filippine 2
SI - Slovenia 2
UA - Ucraina 2
VE - Venezuela 2
AO - Angola 1
AT - Austria 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
CL - Cile 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
IE - Irlanda 1
JM - Giamaica 1
KR - Corea 1
KW - Kuwait 1
MA - Marocco 1
MD - Moldavia 1
MT - Malta 1
NO - Norvegia 1
PL - Polonia 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
Totale 4.515
Città #
Genova 1.525
Genoa 1.323
Rapallo 368
Vado Ligure 283
San Jose 98
Singapore 91
Ashburn 46
Beijing 28
Ho Chi Minh City 25
Lauterbourg 23
Helsinki 21
Hanoi 18
Council Bluffs 17
New York 13
Los Angeles 12
Hong Kong 10
Santa Clara 10
Bordighera 9
Frankfurt am Main 7
Mexico City 6
Toronto 6
Montreal 5
Haiphong 4
Istanbul 4
Paris 4
Phoenix 4
Rome 4
Zurich 4
Amsterdam 3
Chicago 3
Da Nang 3
Haidian 3
Managua 3
Marseille 3
Milan 3
Naples 3
Perugia 3
Sydney 3
São Paulo 3
Tokyo 3
Washington 3
Athens 2
Biên Hòa 2
Boardman 2
Brooklyn 2
Bắc Ninh 2
Cardiff 2
Catania 2
Curitiba 2
Dallas 2
Denver 2
Hải Dương 2
Ljubljana 2
London 2
Madrid 2
Newark 2
Orem 2
Tianjin 2
Trieste 2
Turin 2
Vĩnh Long 2
Acalanes Ridge 1
Algiers 1
Alvorada d'Oeste 1
Amarah 1
Ankara 1
Apucarana 1
Aracaju 1
Araruama 1
Arima 1
As Sālimīyah 1
Ascurra 1
Atlanta 1
Aurangabad 1
Baghdad 1
Baku 1
Baltimore 1
Bandung 1
Bari 1
Barquisimeto 1
Barranquilla 1
Bathurst 1
Belo Horizonte 1
Bengaluru 1
Bertioga 1
Boa Vista 1
Bogotá 1
Brussels 1
Buenos Aires 1
Buffalo 1
Cabo Frio 1
Calamba 1
Calgary 1
Camden 1
Campina Grande do Sul 1
Can Tho 1
Chapada Gaúcha 1
Chennai 1
Chisinau 1
Clear Lake 1
Totale 4.086
Nome #
Depletion of SIRT6 enzymatic activity increases acute myeloid leukemia cells vulnerability to DNA-damaging agents 244
A simple cytofluorimetric score may optimize testing for biallelic CEBPA mutations in patients with acute myeloid leukemia 221
High feasibility and antileukemic efficacy of fludarabine, cytarabine, and idarubicin (FLAI) induction followed by risk-oriented consolidation: A critical review of a 10-year, single-center experience in younger, non M3 AML patients 215
A blastic plasmacytoid dendritic cell neoplasm-like phenotype identifies a subgroup of npm1-mutated acute myeloid leukemia patients with worse prognosis 212
Metabolic starvation triggered by l-asparaginase sensitizes multiple myeloma cells to proteasome inhibitors by inducing DNA damage accumulation 211
Dexamethasone, oxaliplatin and cytarabine (R-DHAOx) as salvage and stem cells mobilizing therapy in relapsed/refractory diffuse large B cell lymphomas 206
Intesive fludarabine-high dose cytarabine-idarubicin combination as induction therapy with risk-adapted consolidation may improve treatment efficacy in younger Acute Myeloid Leukemia (AML) patients: Rationales, evidences and future perspectives 200
Feasibility and Efficacy of Post-Transplant Consolidation Immunotherapy with Nivolumab Supported By the Reinfusion of Unselected Autologous Lymphocytes in Patients Affected By Relapsed/Refractory Hodgkin Lymphoma 195
Combined assessment of WT1 and BAALC gene expression at diagnosis may improve leukemia-free survival prediction in patients with myelodysplastic syndromes 195
Combining flow cytometry and WT1 assessment improves the prognostic value of pre-transplant minimal residual disease in acute myeloid leukemia 193
Early minimal residual disease assessment after AML induction with fludarabine, cytarabine and idarubicin (FLAI) provides the most useful prognostic information 182
Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells 178
Harnessing NK Cells for Cancer Treatment 174
The new small tyrosine-kinase inhibitor ARQ531 targets acute myeloid leukemia cells by disrupting multiple tumor-addicted programs 172
Performance of serum (1,3)-ß-d-glucan screening for the diagnosis of invasive aspergillosis in neutropenic patients with haematological malignancies 171
Longitudinal minimal residual disease (MRD) evaluation in acute myeloid leukaemia with NPM1 mutation: from definition of molecular relapse to MRD-driven salvage approach 167
Chronic graft versus host disease as a weapon for treating chronic myelomonocytic leukemia 165
Adoptive Cell Therapy and Immune Check Points Inhibitors As a Salvage Treatment for Patient Affected By Relapsed/Refractory Hodgkin's Lymphoma 163
Prompt detection of L-asparaginase inactivation is crucial to optimize treatment efficacy also in aggressive lymphomas 150
Cancer immunotherapy by blocking immune checkpoints on innate lymphocytes 148
Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells 144
SIRT6 inhibition as a novel approach for treating Acute Myeloid Leukemia 125
A Blastic Plasmacytoid Dendritic Cell Neoplasm-like Phenotype Identifies a Subgroup of NPM1-Mutated AML Patients with Worse Prognosis While Has Not Predictive Value in NPM1-Wt AML 115
Pre-transplant minimal residual disease assessment and transplant-related factors predict the outcome of acute myeloid leukemia patients undergoing allogeneic stem cell transplantation 96
Long-term real world evidence of CPX-351 of high-risk AML patients identified high rate of negative MRD and prolonged OS 87
Good tolerability of high dose colistin-based therapy in patients with haematological malignancies 84
Early minimal residual disease assessment after AML induction with fludarabine, cytarabine and idarubicin (FLAI) provides the most useful prognostic information 63
Outcome of 421 adult patients with Philadelphia-negative acute lymphoblastic leukemia treated under an intensive program inspired by the GIMEMA LAL1913 clinical trial: a Campus ALL study 45
Levocarnitine supplementation for asparaginase-induced hepatotoxicity in adult acute lymphoblastic leukemia patients: A multicenter observational study of the campus all group 35
The protective role of HCWs communication for the distress of newly diagnosed people with leukemia and lymphoma 34
Multicenter Observational Retrospective Study on Febrile Events in Patients with Acute Myeloid Leukemia Treated with Cpx-351 in "Real-Life": The SEIFEM Experience 23
Counting the Cost: Anticipated Financial Burden and Post-Traumatic Stress Symptoms in Patients Newly Diagnosed with Leukemia and Lymphoma 7
Totale 4.620
Categoria #
all - tutte 14.939
article - articoli 14.370
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.309


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202148 0 0 0 0 0 0 0 0 0 0 0 48
2021/2022311 4 8 22 44 28 28 13 56 26 27 18 37
2022/2023443 38 47 7 41 82 54 2 25 56 28 55 8
2023/2024345 9 27 6 36 22 80 37 74 8 10 18 18
2024/2025835 14 42 21 58 76 99 100 177 23 38 85 102
2025/20261.384 169 36 75 178 176 99 199 52 132 139 78 51
Totale 4.620